Combination of Tremelimumab and Durvalumab Approved by FDA for Unresectable Liver Cancer
October 24th 2022A dual immunotherapy option of tremelimumab, sold as Imjudo, in combination with durvalumab, sold as Imfinzi, was approved by the FDA Monday for the treatment of adult patients with unresectable hepatocellular carcinoma, the most common type of liver cancer.
Read More
Potential Risk Factors Identified for RRT Among Patients With PH
October 24th 2022According to the study authors, acute decompensated pulmonary hypertension (PH) is often accompanied by systemic congestion and right ventricular flow output, and because PH can be accompanied by acute kidney injury, renal replacement therapy (RRT) may be necessary.
Read More
Evaluating Impact of COVID-19 Pandemic on Informal Caregivers of Patients With Parkinson Disease
October 24th 2022Informal caregivers of people with Parkinson disease residing in the United Kingdom discussed challenges faced in providing care during the COVID-19 pandemic, which included risk of infection, lack of access to care, and the impact of lockdown on engaging in activities of daily living.
Read More
Adding Machine Learning to Longitudinal PRO Data May Prove Useful in RA
October 24th 2022In a proof-of-concept analysis, researchers show that machine learning methods paired with longitudinal patient-reported outcomes (PRO) data were able to classify subsequent rheumatoid arthritis (RA) disease activity after beginning treatment with a biologic
Read More
The Biden administration will expand the use of medication to treat substance use disorders to include pregnant women; oversight of the nation’s poorest-performing nursing homes will be tightened; children’s hospitals are filling up with cases of respiratory syncytial virus and other respiratory diseases.
Read More
Dr Melissa O'Connor on Policy Reform to Address Unmet Needs in Home Health
October 23rd 2022Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, discussed several policy needs for home health care, including improved caregiver support, updated eligibility criteria for in-home care, and reimbursement for telehealth.
Read More
Contributor: Congress Must Fix Patient Protection Statute Upended by Supreme Court
October 23rd 2022The author, the dean of the College of Ethnic Studies at California State University Los Angeles, says a Supreme Court ruling could upend insurance protections for patients with kidney diseases, disproportionately hurting those who are Black, Hispanic, Asian, and other diverse ethnicities.
Read More
Identifying ASCT-Ineligible Patients Who Could Benefit From CAR T-Cell Treatment
October 22nd 2022Data suggest that the technology may be an option for patients who are ineligible for autologous stem cell transplantation (ASCT) based on certain patient characteristics, prior treatments, stem cell availability, or tumor chemosensitivity.
Read More
Black Patients’ Uptake of Advanced HF Treatments Falls Behind That of White Patients
October 21st 2022Despite known racial disparities in access to advanced heart failure (HF) treatments, the reasons for this continue to require further exploration. In this new study, investigators searched for associations between ventricular assist device use and heart transplant and race (Black or White).
Read More
2020's Tragedies Propel Student to Examine Race-Based Medical Bias
October 21st 2022A medical student at the University of Kansas discusses a research project she started in her first year of school—2020—looking at whether a racial bias in pulse oximetry was present in patients with acute hypoxemic respiratory failure.
Watch
Albumin Injections Linked to Improved Brain Function, QOL in Patients With Liver Cirrhosis
October 21st 2022Researchers also found an improvement in specialized blood markers focusing on inflammation, endothelial dysfunction, and albumin function in patients receiving weekly albumin injection.
Read More
Racial Disparities Shown for Influenza Hospitalizations, Vaccination Coverage
October 20th 2022CDC's latest Morbidity and Mortality Weekly Report showed that US adults of non-Hispanic Black, American Indian or Alaska Native, and Hispanic race/ethnicity exhibited significantly higher influenza hospitalization rates and lower vaccination coverage compared with White adults.
Read More
Dr Neil Gross: QOL Improvement Likely Following Treatment With Cemiplimab for cSCC
October 20th 2022Patients may be able to forgo radiation following use of cemiplimab to treat their resectable cutaneous squamous cell carcinoma (cSCC), as it is likely to demonstrate significant improvement in quality of life (QOL) for patients and enable less invasive surgeries, noted Neil D. Gross, MD, FACS, head and neck surgeon and director of clinical research in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center.
Watch